Loading…
Denmark‘s economy is heading for slower growth as the pharmaceutical boom led by Novo Nordisk A/S loses steam and the industry settles into a pace more in line with the rest of the economy, the country’s financial watchdog said.
To respect copyright, we link to the source rather than republishing the full text. Read the complete article on Bloomberg.